Stroke AI Market Set to Surge at 38.4% CAGR, Reaching USD 1.60 Billion by 2030

Stroke AI Market Set to Surge at 38.4% CAGR, Reaching USD 1.60 Billion by 2030
Stroke AI Market by Offering (Software, [AI], Services), Classification (ICD, CPT, HCPCS), Specialty (Surgical, Radiology), Function (Code, Assignment, Reimbursement, Analytics, Denial, Audit), End User (Hospital, ASC, Payers) – Global Forecast to 2030

The global Stroke AI Market is projected to grow from USD 0.32 billion in 2025 to USD 1.60 billion by 2030, registering an exceptional compound annual growth rate (CAGR) of 38.4% during the forecast period. This rapid expansion underscores a pivotal shift in how healthcare systems leverage artificial intelligence (AI) to enhance stroke diagnosis, triage, reimbursement accuracy, and clinical outcomes.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144234354

Why Stroke AI Is Gaining Strategic Priority

What is driving this exponential growth? The answer lies in the escalating global burden of stroke and the urgent need for faster, data-driven decision-making in acute care settings.

According to the Stroke Foundation’s Economic Impact of Stroke Report, Australia recorded 45,785 stroke cases in 2023—the highest in over two decades. In India, more than 1.8 million individuals are affected annually, and the Indian Stroke Association (ISA) estimates that nearly 80% of strokes could be prevented with timely intervention.

How are healthcare systems responding? Hospitals and care providers are increasingly deploying AI-powered solutions to analyze CT and MRI scans in real time. These platforms accelerate image interpretation, detect abnormalities such as large-vessel occlusions (LVO), and support immediate clinical triage—where every minute directly impacts patient survival and neurological outcomes.

For C-suite leaders, this shift represents not just a clinical upgrade but a strategic investment in workflow efficiency, reimbursement optimization, and competitive differentiation.

Hospitals Lead Adoption as First-Line Stroke Care Hubs

By end user, the hospitals segment accounted for the largest share of the stroke AI market in 2024.

Why hospitals? They serve as the primary point of contact for stroke diagnosis, triage, and intervention. AI-enabled stroke platforms are being integrated into emergency departments and radiology workflows to automate image review, notify care teams instantly, and streamline clinical pathways.

For example, in January 2026, Gleneagles Hospital in Parel, India, launched an AI-based hub-and-spoke stroke care model. This system connects peripheral diagnostic centers with a centralized stroke team, enabling faster detection of LVOs and improving patient triage. Such models illustrate how AI enhances operational coordination across distributed healthcare networks.

For hospital administrators and healthcare CFOs, AI adoption translates into faster turnaround times, improved throughput, better reimbursement capture, and reduced diagnostic variability.

Ischemic Stroke Segment Dominates Due to Clinical Urgency and Prevalence

By indication, the ischemic stroke segment dominated the stroke AI market in 2024.

Why is ischemic stroke leading? It accounts for the majority of stroke cases globally and requires rapid diagnosis to determine eligibility for thrombolysis or mechanical thrombectomy. AI solutions play a critical role in: Detecting large vessel occlusions (LVO), Calculating Alberta Stroke Program Early CT Score (ASPECTS), Performing automated perfusion analysis and Generating real-time triage alerts

Companies such as Brainomix and Aidoc are advancing automated CT-based stroke assessments, enabling emergency teams to make time-sensitive decisions with greater precision and confidence.

For healthcare executives, this indicates sustained long-term demand for AI-enabled neuroimaging and stroke workflow optimization tools.

Asia Pacific Emerging as the Fastest-Growing Regional Market

Where is the fastest growth expected? The Asia Pacific region is projected to witness the highest growth rate during the forecast period.

The region’s expanding patient population, rising stroke incidence, and accelerating digital health adoption are fueling demand. Hospitals across Asia are actively integrating AI into acute stroke management.

In December 2025, Hallym University Sacred Heart Hospital in South Korea adopted JLK’s AI brain imaging software to analyze CT and MRI scans for stroke assessment. This reflects a broader regional trend toward AI-enabled neuroimaging and advanced clinical decision support systems.

For multinational healthcare technology providers and investors, Asia Pacific presents a high-growth opportunity driven by both clinical necessity and rapid infrastructure modernization.

Strategic Market Implications for Decision-Makers

What does this mean for industry stakeholders?

1. Hospitals & Health Systems: Opportunity to enhance emergency care performance metrics and optimize reimbursement workflows.

2. AI & HealthTech Vendors: Strong demand for scalable, interoperable AI imaging platforms integrated with ICD, CPT, and HCPCS classification systems.

3. Investors & Private Equity: High CAGR and strong clinical drivers signal sustained capital deployment potential.

4. Payers: Advanced AI analytics support coding accuracy, denial management, and improved claims processing efficiency.

As healthcare systems prioritize time-to-treatment and value-based care, AI in stroke management is shifting from innovation to operational necessity.

Request For Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=144234354

Key Market Participants

The report profiles leading players including Aidoc (US), Siemens Healthineers AG (Germany), RapidAI (US), Brainomix (UK), Canon Medical Systems Corporation (Japan), Viz.ai, Inc. (US), Infervision (China), and Behold.ai (UK), among others.

Strategic Outlook

The study analyzes the Stroke AI Market by Offering (Software, AI, Services), Classification (ICD, CPT, HCPCS), Specialty (Surgical, Radiology), Function (Code Assignment, Reimbursement, Analytics, Denial Management, Audit), and End User (Hospitals, ASCs, Payers), providing a comprehensive global forecast to 2030.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/stroke-ai-market-144234354.html